PERMIXON 160 mg, hard capsule 60 capsules
Active ingredients: SERENOA REPENS (EXTRAIT LIPIDO-STÉROLIQUE DE)
Commercialized according to BDPM
Hard capsule60 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PERMIXON 160 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC-Aluminium de 60 gélule(s)
- Marketing authorisation holder
- DIFARMED (ESPAGNE)
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 27 Oct 2023
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66515809CIP74902320CIP133400949023202Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SERENOA REPENS (EXTRAIT LIPIDO-STÉROLIQUE DE)gélule | 160 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.